Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 3196 AL 3210

Cerebrospinal Fluid Biomarkers and Cognition in Alzheimer Disease and Frontotemporal Dementia in a Memory Clinic Setting

Cayir S, Sadabad FE, Mecca AP, Matuskey D, Fesharaki-Zadeh A.

Alzheimer Dis Assoc Disord. 2025 Jan-Mar 01;39(1):22-27. doi: 10.1097/WAD.0000000000000656. Epub 2025 Jan 13.

Association between Serum Levels of Interleukin-6 and Stroke, Cardiovascular Events, and Alzheimer's Disease Dementia

Kitagawa K, Toi S, Yoshizawa H, Sato Y, Todo K.

J Atheroscler Thromb. 2025 Nov 1;32(11):1390-1399. doi: 10.5551/jat.65763. Epub 2025 Jun 6.

The neuroinflammatory role of microRNAs in Alzheimer's disease: pathological insights to therapeutic potential

Liu W, Rao X, Sun W, Chen X, Yu L, Zhang J, Chen J, Zheng X.

Mol Cell Biochem. 2025 May;480(5):2689-2706. doi: 10.1007/s11010-024-05164-0. Epub 2024 Nov 20.

Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer's diseases

Alshehri ZS.

Neuroscience. 2025 Nov 1;586:44-57. doi: 10.1016/j.neuroscience.2025.08.055. Epub 2025 Sep 18.

Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment

Alvarez-Sanchez L, Pereto M, Garcia-Valles L, Balaguer A, Pena-Bautista C, Ferre-Gonzalez L, Baquero M, Pericas CC.

Curr Neuropharmacol. 2025;23(5):602-611. doi: 10.2174/011570159X332930240925095423.

Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review

Scribano Parada MP, González Palau F, Valladares Rodríguez S, Rincon M, Rico Barroeta MJ, García Rodriguez M, Bueno Aguado Y, Herrero Blanco A, Díaz-López E, Bachiller Mayoral M, Losada Durán R.

JMIR Med Inform. 2025 Jan 28;13:e62914. doi: 10.2196/62914.

Near-Infrared Fluorescent Probe for the Early Diagnosis of Alzheimer's Disease

Liu Y, Sun Y, Zhao P, Liu Z, Wang Y, Wang Y, Zhao R, Wang C, Wang S.

Med Res Rev. 2026 Jan;46(1):5-39. doi: 10.1002/med.70000. Epub 2025 Jul 28.

Blood biomarkers for diagnosis and differential diagnosis of Alzheimer's disease in real-world clinical populations: A systematic review

Suresh S, Maffei L, Bauermeister S, Raymont V.

J Alzheimers Dis. 2026 Feb;109(4):1574-1589. doi: 10.1177/13872877251408510. Epub 2025 Dec 29.

Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study

Guillén N, Contador J, Buongiorno M, Álvarez I, Culell N, Alcolea D, Lleó A, Fortea J, Piñol-Ripoll G, Carnes-Vendrell A, Lourdes Ispierto M, Vilas D, Puig-Pijoan A, Fernández-Lebrero A, Balasa M, Sánchez-Valle R, Lladó A.

Eur Arch Psychiatry Clin Neurosci. 2025 Feb;275(1):257-266. doi: 10.1007/s00406-023-01701-y. Epub 2023 Oct 28.

The diagnostic value of plasma Aβ42 and Aβ40 in Alzheimer's disease: current status, challenges, and impacting variables

Duan X, Wang F, Liu W, Xie Y, Yang M, Ping Y, Yu P, Wei Z, Li H, Zhang Q, Wang X, Tao Z.

J Neurol. 2025 Dec 17;273(1):30. doi: 10.1007/s00415-025-13346-z.

Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and design for a 12-month randomized trial

Ptomey LT, Donnelly JE, Burns J, Morris J, Hartley S, Martin LE, Choi IY, Lee P, Li Y, Hunt S, Sherman JR, Danon JC, Brucks MG, Koon L, Spaeth K, Sullivan DK.

Alzheimers Dement. 2025 Apr;21(4):e70219. doi: 10.1002/alz.70219.

Interplay between CD33 and TREM2 in Alzheimer's Disease: Potential Mechanistic Insights into Microglial Function in Amyloid Pathology

Akinluyi ET, Takahashi-Yamashiro K, Connolly MG, Poon WW, Macauley MS.

ACS Chem Neurosci. 2026 Jan 7;17(1):62-76. doi: 10.1021/acschemneuro.5c00805. Epub 2025 Dec 12.

Predictive modeling approaches for Alzheimer's disease diagnosis through neuroimaging techniques

Pandey KK, Mishra A, Milan R.

Ageing Res Rev. 2026 Jan;114:102989. doi: 10.1016/j.arr.2025.102989. Epub 2025 Dec 8.

Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease

Wisch JK, McKay NS, Zammit M, Christian BT, Schultz SA, Millar PR, Ryan NS, Cash DM, Belder CRS, Chrem P, Cruchaga C, Ibanez L, Jucker M, Yakushev I, Day GS, Murphy M, Llibre-Guerra J, Aguillon D, Roh JH, Xiong C, Wang G, Li Y, Schindler SE, Jack C, McDade E, Bateman RJ, Benzinger TLS, Ances BM; Dominantly Inherited Alzheimer Networ; Betthauser T, Gordon B.

Alzheimers Dement. 2025 Oct;21(10):e70812. doi: 10.1002/alz.70812.

Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer's Disease

Hey JA, Yu JY, Abushakra S, Schaefer JF, Power A, Kesslak P, Paul J, Tolar M.

Clin Pharmacokinet. 2025 Mar;64(3):407-424. doi: 10.1007/s40262-025-01482-8. Epub 2025 Feb 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias